✦ LIBER ✦

Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation

✍ Scribed by Jean-Claude Davin; Charles Majoie; Jaap Groothoff; Valentina Gracchi; Antonia Bouts; Timothy H. J. Goodship; Chantal Loirat

Publisher: Springer
Year: 2010
Tongue: English
Weight: 203 KB
Volume: 26
Category: Article
ISSN: 0931-041X
DOI: 10.1007/s00467-010-1608-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of plasma therapy in atypical h

Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor

✍ Anne-Laure Lapeyraque; Eric Wagner; Véronique Phan; Marie-José Clermont; Aïcha M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 119 KB

A case of atypical hemolytic uremic synd

A case of atypical hemolytic uremic syndrome with a transient decrease in complement factor H

✍ Hyewon Hahn; Eun Young Um; Young Seo Park; Hae Il Cheong 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 130 KB

Efficacy of eculizumab in a patient with

Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome

✍ Anne-Laure Lapeyraque; Véronique Frémeaux-Bacchi; Pierre Robitaille 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 308 KB

De novo gene conversion in the RCA gene

De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome

✍ Stefan Heinen; Pilar Sanchez-Corral; Michael S Jackson; Lisa Strain; Judith A. G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

Many of the complement regulatory genes within the RCA cluster (1q32) have arisen through genomic duplication and the resulting high degree of sequence identity is likely to predispose to gene conversion events. The highest degree of identity is between the genes for factor H (CFH) and five factor H